Chitosan-EDTA new combination is a promising candidate for treatment of bacterial and fungal infections

Current Microbiology

Volumn 62, Issue 3, 2011, Pages 739-745

  El Sharif, Amany A ^a   Hussain, Mohamed H M ^b  

^a Al Azhar University   (Egypt)

^b EGYPTIAN PETROLEUM RESEARCH INSTITUTE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; CHITOSAN DERIVATIVE; EDETIC ACID; HYDROCHLORIC ACID;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CANDIDA ALBICANS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG POTENTIATION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CANDIDA ALBICANS; CHITOSAN; DRUG SYNERGISM; EDETIC ACID; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY;

BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 79954445186     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-010-9777-0     Document Type: Article

References (31)

1. AG Al-Bakri G Othman Y Bustanji 2009 The assessment of the antibacterial and antifungal activities of aspirin, EDTA and aspirin-EDTA combination and their effectiveness as antibiofilm agents J Appl Microbiol 107 1 280 286 19302313 10.1111/j.1365-2672.2009.04205.x 1:CAS:528:DC%2BD1MXosl2jt7Y%3D
2. MO Taha AG Al-Bakri WA Zalloum 2006 Discovery of potent inhibitors of pseudomonal quorum sensing via pharmacophore modeling and in silico screening Bioorg Med Chem Lett 16 22 5902 5906 16945524 10.1016/j.bmcl.2006.08.069 1:CAS:528:DC%2BD28XhtVCrt7rI (Pubitemid 44486725)
3. Roberts GAF (1992) Chitin chemistry. Palgrave Macmillan, London
4. CY Cheng YK Li 2000 An Aspergillus chitosanase with potential for large-scale preparation of chitosan oligosaccharides Biotechnol Appl Biochem 32 Pt 3 197 203 11115392 10.1042/BA20000063 1:CAS:528:DC%2BD3MXktVGqsg%3D%3D (Pubitemid 32053172)
5. E Gavini, et al. 2002 Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine AAPS PharmSciTech 3 3 E20 12916935 10.1208/pt030320
6. S Tin, et al. 2009 Activity of Chitosans in combination with antibiotics in Pseudomonas aeruginosa Int J Biol Sci 5 2 153 160 19173037 1:CAS:528:DC%2BD1MXnsl2rtbo%3D
7. I Raad, et al. 2007 Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm Antimicrob Agents Chemother 51 1 78 83 17074799 10.1128/AAC.00154-06 1:CAS:528:DC%2BD2sXktValsA%3D%3D (Pubitemid 46047690)
8. DM Reardon B Warner EA Trowbridge 1991 EDTA, the traditional anticoagulant of haematology: with increased automation is it time for a review? Med Lab Sci 48 1 72 75 1905774 1:STN:280:DyaK3M3oslCqsg%3D%3D
9. M Vaara 1992 Agents that increase the permeability of the outer membrane Microbiol Rev 56 3 395 411 1406489 1:CAS:528:DyaK3sXjsFCktQ%3D%3D
10. HM Ashour A El-Sharif 2007 Microbial spectrum and antibiotic susceptibility profile of gram-positive aerobic bacteria isolated from cancer patients J Clin Oncol 25 36 5763 5769 18089873 10.1200/JCO.2007.14.0947
11. HM Ashour A El-Sharif 2009 Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patients J Transl Med 7 1 14 10.1186/1479-5876-7-14
12. L Drago E De Vecchi L Nicola MR Gismondo 2007 In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections BMC Infect Dis 7 111 17888153 10.1186/1471-2334-7-111 (Pubitemid 47604308)
13. Black JG (1999) Microbiology : principles and explorations, 4th edn, International edn. Upper Saddle River, N.J.: Prentice Hall International; [Great Britain : Wiley]. 1 v. (various pagings)
14. Schwalbe R, Steele-Moore L, Goodwin AC (2007) Antimicrobial susceptibility testing protocols. CRC Press, Boca Raton, p 414
15. R Cooper L Jenkins 2009 A comparison between medical grade honey and table honeys in relation to antimicrobial efficacy Wounds 21 2 29 36
16. WH Wang, et al. 2003 Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents Gut 52 4 490 495 12631656 10.1136/gut.52.4.490 1:CAS:528:DC%2BD3sXjtVKltLo%3D (Pubitemid 36363398)
17. JJ Harrison RJ Turner H Ceri 2007 A subpopulation of Candida albicans and Candida tropicalis biofilm cells are highly tolerant to chelating agents FEMS Microbiol Lett 272 2 172 181 17490429 10.1111/j.1574-6968.2007.00745.x 1:CAS:528:DC%2BD2sXnslyhsbo%3D (Pubitemid 47074598)
18. RL White, et al. 1996 Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test Antimicrob Agents Chemother 40 8 1914 1918 8843303 1:CAS:528:DyaK28Xks12qurc%3D (Pubitemid 26277815)
19. JA Bosso 2005 The antimicrobial armamentarium: evaluating current and future treatment options Pharmacotherapy 25 10 Pt 2 55S 62S 16178676 10.1592/phco.2005.25.10part2.55S 1:CAS:528:DC%2BD2MXhtFKnsrnN (Pubitemid 41407622)
20. BS Fazly-Bazzaz M Khajehkaramadin HR Shokooheizadeh 2005 In vitro antibacterial activity of Rheum ribes extract obtained from various plant parts against clinical isolates of Gram-negative pathogens Iranian J Pharm Res 2 87 91
21. ME Falagas, et al. 2005 Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria BMC Infect Dis 5 1 24 15819983 10.1186/1471-2334-5- 24 (Pubitemid 41363802)
22. J Gomez, et al. 2009 Nosocomial candidemia at a general hospital: the change of epidemiological and clinical characteristics. A comparative study of 2 cohorts (1993-1998 versus 2002-2005) Rev Iberoam Micol 26 3 184 188 19635438 10.1016/j.riam.2009.02.003
23. M Mehta P Dutta V Gupta 2005 Antimicrobial susceptibility pattern of blood isolates from a teaching hospital in north India Jpn J Infect Dis 58 3 174 176 15973011 1:CAS:528:DC%2BD2MXmvFWntL8%3D (Pubitemid 41460597)
24. D Raafat, et al. 2008 Insights into the mode of action of chitosan as an antibacterial compound Appl Environ Microbiol 74 12 3764 3773 18456858 10.1128/AEM.00453-08 1:CAS:528:DC%2BD1cXnvFWlsLs%3D (Pubitemid 351874908)
25. Z Zhong, et al. 2009 Antimicrobial activity of hydroxylbenzenesulfonailides derivatives of chitosan, chitosan sulfates and carboxymethyl chitosan Int J Biol Macromol 45 2 163 168 19414029 10.1016/j.ijbiomac.2009.04.020 1:CAS:528:DC%2BD1MXnsFOhu70%3D
26. P Aksungur, et al. 2004 Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies J Control Release 98 2 269 279 15262418 10.1016/j.jconrel.2004.05.002 1:CAS:528:DC%2BD2cXlslGisL8%3D (Pubitemid 38950736)
27. B Loretz A Bernkop-Schnurch 2006 In vitro evaluation of chitosan-EDTA conjugate polyplexes as a nanoparticulate gene delivery system AAPS J 8 4 E756 764 17285741 10.1208/aapsj080485 1:CAS:528:DC%2BD2sXnsFKrsQ%3D%3D
28. E Banin KM Brady EP Greenberg 2006 Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm Appl Environ Microbiol 72 3 2064 2069 16517655 10.1128/AEM.72.3.2064-2069.2006 1:CAS:528:DC%2BD28XjsFCmtro%3D
29. P Kite, et al. 2004 Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro J Clin Microbiol 42 7 3073 3076 15243062 10.1128/JCM.42.7.3073-3076.2004 1:STN:280:DC%2BD2czktV2muw%3D%3D (Pubitemid 38938060)
30. SL Percival, et al. 2005 Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm Infect Control Hosp Epidemiol 26 6 515 519 16018425 10.1086/502577 (Pubitemid 40896140)
31. RJ Sherertz, et al. 2006 Comparative in vitro efficacies of various catheter lock solutions Antimicrob Agents Chemother 50 5 1865 1868 16641463 10.1128/AAC.50.5.1865-1868.2006 1:CAS:528:DC%2BD28XksVKktbY%3D